Immatics Competitors and Similar CompaniesClear all

Immatics's competitors and similar companies include Tessa Therapeutics and Juno Therapeutics.
Immatics
Immatics
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
Tessa Therapeutics
Tessa Therapeutics
Tessa Therapeutics is a clinical-stage biotechnology company focused on the cancer treatment development.
Juno Therapeutics
Juno Therapeutics
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
Founding Date
Founding Date
N/A
Founding Date
2011
Founding Date
2013
Type
Type
Public
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Tübingen, DE HQ
Frankfurt Am Main, DE
München, DE
Houston, US
Locations
Singapore, SG HQ
Locations
Seattle, US HQ
Göttingen, DE
Göttingen, DE
München, DE
München, DE
Bothell, US
Brisbane, US
Employees
Employees
29723% increase
Employees
432% increase
Employees
1091% decrease

Financial

Revenue (est.)
Revenue (est.)
€48.3m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
$111.9m (FY, 2017)
Net income
Net income
(€196.4m) (FY, 2025)
Net income
N/A
Net income
($437.1m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 267.3m
Total funding raised
$ 80m
Total funding raised
$ 310m
For sources of this data, please see the company profile

View Company Profiles

Tessa Therapeutics
HQ
Singapore, SG
Employees
43↑ 2% increase

Tessa Therapeutics is a clinical-stage biotechnology company focused on the cancer treatment development.

View company
Juno Therapeutics
HQ
Seattle, US

Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.

View company